Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SNAP vs GSK✓SelectedUSD · GSKSNAP vs GSK performance historyLatest closeAs of-1.09%11/18
Stock and ETF performance explorer

SNAP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-34.1%
GSK return
+7.0%
Excess return
-41.0%
Maximum drawdown
-55.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.1%-1.3%+0.2%-1.0%
7D+1.9%-3.1%+5.0%+2.0%
30D-13.2%-0.9%-12.3%-13.2%
3M+6.5%-4.2%+10.6%+6.8%
6M-4.1%-1.6%-2.5%-3.7%
YTD-32.6%+2.6%-35.2%-34.7%
1Y-34.1%+6.2%-40.3%-36.3%
All-34.1%+7.0%-41.0%-36.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling